The company has a big data advantage with Westlaw. Can it turn this into legal intelligence that's smarter than OpenAI's ...

A marketwide sell-off in the crypto sector is hitting various tokens and companies differently. Canaan is among the hardest ...

Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial ...

Learn more about how Microsoft Security Copilot, powered by generative AI, can empower security operation center in our ...

The industry's 2010s-era foray into self-driving didn't really pay off for many automakers. General Motors-backed Cruise lit ...

Melrose Industries is a strong buy with 20% upside, benefiting from aerospace exposure and margin growth. Click here to read ...

Fiserv is a critical fintech player facing short-term challenges but remains essential and undervalued. Read why now is the ...

In the meantime, the company could generate consistent financial results and superior stock market performance, given the ...

Former Vice President Dick Cheney, a defense hawk and architect of the second Iraq war, dies at 84. NBC News' Chief Data ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...